Effect of zinc on the treatment of depression and multiple sclerosis

Phase 3

• Conditions: Multiple sclerosis; Condition 1: depression. Condition 2: Multiple sclerosis.; Recurrent depressive disorder

• Registration Number: IRCT2012081010550N1
• Lead Sponsor: Kurdistan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

having major depressive disorder based on the beck questionnaire with a score of 19; MS patients according to clinical and paraclinical findings. Exclusion criteria: having a personality disorder; Education below than elementary fifth; symptoms of a psychotic disorder; other neurological disorders except MS; Serious disease including renal failure, hepatic insufficiency, ischemic heart disease, cancer, endocrine and metabolic diseases based on clinical records.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Muscle strength. Timepoint: baseline the study and after three months. Method of measurement: scoring 0-5.;Balance. Timepoint: baseline the study and after three months. Method of measurement: examination (Romberg test,Tandem gate test).;Depression. Timepoint: baseline the study and after three months. Method of measurement: Beck Depression Inventory.;Nystagmus. Timepoint: baseline the study and after three months. Method of measurement: examination.